Net profit of Bal Pharma rose 9.47% to Rs 1.04 crore in the quarter ended September 2024 as against Rs 0.95 crore during the previous quarter ended September 2023. Sales declined 20.37% to Rs 73.69 crore in the quarter ended September 2024 as against Rs 92.54 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 73.69 | 92.54 | -20 |
| OPM % | 10.44 | 8.32 | - |
| PBDT | 3.84 | 4.02 | -4 |
| PBT | 1.36 | 1.60 | -15 |
| NP | 1.04 | 0.95 | 9 |